Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
+1.36M
-
Total reported value, excl. options
-
$516M
-
Value change
-
+$44.9M
-
Number of buys
-
97
-
Number of sells
-
-49
-
Price
-
$33.48
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q2 2018
172 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q2 2018.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 22.7M outstanding shares and own 67.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.43M shares), Conestoga Capital Advisors, LLC (1.39M shares), VANGUARD GROUP INC (1.14M shares), DIMENSIONAL FUND ADVISORS LP (1.01M shares), Epoch Investment Partners, Inc. (932K shares), Ranger Investment Management, L.P. (700K shares), JANUS HENDERSON GROUP PLC (692K shares), STATE STREET CORP (566K shares), THOMSON HORSTMANN & BRYANT INC (392K shares), and AWM Investment Company, Inc. (350K shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.